RNA, U1 small nuclear 52, pseudogene (RNU1-52P)

RNU1-52P is a pseudogene sequence related to U1 small nuclear RNA, a key component of spliceosomal machinery responsible for pre-mRNA splicing in eukaryotic cells[4][1]. While the canonical U1 snRNA is vital for recognizing splice sites and facilitating splicing, pseudogenes like RNU1-52P are traditionally considered nonfunctional due to sequence disruptions, deletions, or insertions[2]. However, research on U1 snRNA pseudogenes collectively suggests that some variant pseudogene-derived snRNAs can be transcribed, processed, and incorporated into ribonucleoprotein complexes, possibly exerting regulatory effects on gene expression and mRNA 3' end processing in specific contexts[2]. RNU1-52P is not a validated therapeutic or diagnostic target, and its individual function, if any, remains uncharacterized and likely negligible. There is no evidence of disease associations or drug interactions specific to RNU1-52P. RNU1-52P’s designation as a pseudogene means it does not encode functional U1 snRNA and is generally not transcribed or translated as an active RNA or protein. While the U1 snRNA family itself underpins spliceosomal function[4] and some pseudogenes can, in rare cases, exert non-coding regulatory roles, there is no evidence that RNU1-52P is directly involved in any such activity[2][1]. RNU1-52P is not a valid therapeutic target, not a receptor, enzyme, transporter, or typical molecular target. Its mention as a target is likely due to confusion with the canonical U1 snRNA or with functionally relevant U1 variant pseudogenes that have biological functions documented only in a small subset of cases[2]. If you seek structured information for a druggable target, RNU1-52P is not appropriate; further investigation should focus on canonical U1 snRNA (RNU1-1) or validated pseudogenes with experimentally demonstrated biological activity[1][2][4].

Other names

RNU1-52PU1 small nuclear RNA pseudogeneU1 snRNA pseudogene